Literature DB >> 11011778

Femoral recon nails for metastatic disease: indications, technique, and results.

W G Ward1, J Spang, D Howe, S Gordan.   

Abstract

The senior author has used 41 femoral recon nails of one design in 41 consecutive patients with 30 impending and 11 pathologic femur fractures. All nails were inserted with minimally invasive surgical technique. The hospital stay was shorter (average, 5.6 days) and discharge to home was more likely (77%) after stabilization of impending pathologic fractures compared with fixation of completed fractures (length of hospital stay averaged 7.8 days, with a 36% discharge-to-home rate), as patients with completed fractures required a higher level of postoperative care. Fixation prior to fracture occurrence results in predictably better early results than that of fixation after fracture occurrence, confirming the benefit of prophylactic fixation of impending pathologic fractures. To date, there have been no fixation failures and only one significant complication: a nonfatal pulmonary embolus. This technique provides a safe and effective method of stabilizing properly selected femoral lesions resulting from metastatic disease, especially impending pathologic fractures.

Entities:  

Mesh:

Year:  2000        PMID: 11011778

Source DB:  PubMed          Journal:  Am J Orthop (Belle Mead NJ)        ISSN: 1078-4519


  3 in total

1.  Inter- and intra-observer variability associated with the use of the Mirels' scoring system for metastatic bone lesions.

Authors:  Ruairi F Mac Niocaill; John F Quinlan; Robert D Stapleton; Brian Hurson; Sean Dudeney; Gary C O'Toole
Journal:  Int Orthop       Date:  2010-01-19       Impact factor: 3.075

2.  Metastatic bone disease: the requirement for improvement in a multidisciplinary approach.

Authors:  D Cumming; J Cumming; A Vince; R Benson
Journal:  Int Orthop       Date:  2008-04-23       Impact factor: 3.075

3.  Is a Cephalomedullary Nail Durable Treatment for Patients With Metastatic Peritrochanteric Disease?

Authors:  David H Chafey; Valerae O Lewis; Robert L Satcher; Bryan S Moon; Patrick P Lin
Journal:  Clin Orthop Relat Res       Date:  2018-12       Impact factor: 4.176

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.